Member Info for RayPointer

Cleaner

Surely Sath himself is the link

😂

Actually Burnley have never been beaten by Real, but Mansfield Town is another matter.

Https://www.england.nhs.uk/2026/06/nhs-rolls-out-life-extending-drug-for-hundreds-of-women-with-ovarian-cancer/

"In a major global clinical trial involving eight NHS hospitals. the treatment delayed cancer progression and prolonged survival, with patients living 16.5 months on average compared to 12.8 months with chemotherapy."

Good news for patients but not relevant to Scancell at all.

I'm told the 2nd leg is immediately after the next RNS. Traders United are non too pleased

Looks like Traders United have taken a half-time lead but Investors Academicals are fighting back in the second half

Discover a company with brilliant science, invest at a low price, sit back and enjoy. 😎

Vascular

Using the Trinity method of valuation:

https://www.trinitydelta.org/research-notes/abundant-development-opportunities-in-immuno-oncology/

"Valuation

We value Scancell using a sum-of-the parts, where the rNPVs of the three distinct technology platforms are summed together with cash. Within each, we have a standalone valuation for the clinical assets (ie iSCIB1+ and Modi-1) plus indicative placeholder platform valuations. Our Scancell valuation is £382m ($477m), or 37p per share (31p fully diluted), with iSCIB1+ the most important contributor, worth >50%. We value the ImmunoBody platform (which includes iSCIB1+) at £215m/$269m, with upside to our iSCIB1+ peak sales forecasts, in addition to upcoming de-risking events which could lift the ImmunoBody valuation alone to £346m/$432m; these include further iSCIB1+ survival data, FDA feedback on the registrational trial design, and clarity on the funding for this trial."

If funding is sorted, Trinity reckons the iSCIB1+ valuation changes from £215 m to £346 m. Hence the total valuation changes from £382 m to £513 m. I reckon the undiluted valuation then changes to 49p i.e (37 x 513 ) / 382

But that's Trinity and not Panmure.

Moderna guy to Lindy after Lindy's conference presentation "If you're right, then we (Moderna) are in trouble"

"The course of true love never did run smooth" 💘

Interesting, but we all should be familiar with the original SCIB1 trial results with the main tumour resected. Small numbers in that trail but comparable results using SCIB1 alone without CPIs.

For those who aren't familiar see page 6 of the following:

https://scancell.co.uk/wp-content/uploads/2024/10/aacr-2024-scib1-.pdf

"Metastatic patients without tumour present at study entry

88% of melanoma patients remained disease-free for 5+ years"

C11

Post recommended

😎🙏🤣🌭😒

Well if any big pharma is still unaware of the Scope trial results, they need shooting 😂

It's wonderful to see that iSCIB1+ is achieving such fine trial results.

This is despite set-backs like patent running out, pharma not liking electoporation, the device not getting FDA approval when we were set for a trial in the US.

It just shows what a tenacious scientist Lindy is. She has such faith in her own science.

What price Scancell if the Modi1 results are equally as good?

What on earth has happened to notpotalot's fan club?

Yeah, and when the tele plays up, as it does frequently, you just get up and give it a hard slap.

No couch potatoes in Burnley

" adjusting the TV volume to an even number."

What does this mean? I just turn the volume knob.

VD, we'll have a whip-round for those 3 shares

Https://find-and-update.company-information.service.gov.uk/company/14409383/filing-history

I see Ambrose have filed accounts up to 31st March this year. They only have 1 employee (down from 2 last year) and still have hardly a couple of pennies to rub together.

This is despite team ramp claiming that they had recruited a high quality team of experts.

This lack of cash and employees may explain why VAL401 is now missing from the bullet point list.

Mark had to talk fast to get through all the bullet points

I agree with everything you say, monkster.

Put simply, the chart is now agreeing with the fundamentals in a more or less consistent manner.

Don't tell Zak 😂